Luye Pharma Group Balance Sheet Health
Financial Health criteria checks 5/6
Luye Pharma Group has a total shareholder equity of CN¥13.5B and total debt of CN¥8.4B, which brings its debt-to-equity ratio to 61.7%. Its total assets and total liabilities are CN¥25.5B and CN¥12.0B respectively. Luye Pharma Group's EBIT is CN¥887.4M making its interest coverage ratio 1.9. It has cash and short-term investments of CN¥6.1B.
Key information
61.7%
Debt to equity ratio
CN¥8.35b
Debt
| Interest coverage ratio | 1.9x |
| Cash | CN¥6.11b |
| Equity | CN¥13.53b |
| Total liabilities | CN¥11.96b |
| Total assets | CN¥25.49b |
Recent financial health updates
Here's Why Luye Pharma Group (HKG:2186) Has A Meaningful Debt Burden
Apr 26
Luye Pharma Group (HKG:2186) Takes On Some Risk With Its Use Of Debt
Dec 19Is Luye Pharma Group (HKG:2186) A Risky Investment?
Sep 12Is Luye Pharma Group (HKG:2186) Using Too Much Debt?
May 10We Think Luye Pharma Group (HKG:2186) Is Taking Some Risk With Its Debt
Sep 20Recent updates
Here's Why Luye Pharma Group (HKG:2186) Has A Meaningful Debt Burden
Apr 26Is Luye Pharma Group Ltd. (HKG:2186) Trading At A 27% Discount?
Feb 29Some Confidence Is Lacking In Luye Pharma Group Ltd.'s (HKG:2186) P/S
Jan 09Luye Pharma Group (HKG:2186) Takes On Some Risk With Its Use Of Debt
Dec 19A Look At The Fair Value Of Luye Pharma Group Ltd. (HKG:2186)
Nov 24Is Luye Pharma Group (HKG:2186) A Risky Investment?
Sep 12Luye Pharma Group Ltd.'s (HKG:2186) Intrinsic Value Is Potentially 20% Below Its Share Price
Aug 17Is Luye Pharma Group (HKG:2186) Using Too Much Debt?
May 10We Think Luye Pharma Group (HKG:2186) Is Taking Some Risk With Its Debt
Sep 20Time To Worry? Analysts Just Downgraded Their Luye Pharma Group Ltd. (HKG:2186) Outlook
Apr 06Luye Pharma Group's (HKG:2186) Shareholders Are Down 31% On Their Shares
Mar 17A Closer Look At Luye Pharma Group Ltd.'s (HKG:2186) Impressive ROE
Feb 19
Is Luye Pharma Group Ltd. (HKG:2186) Trading At A 49% Discount?
Feb 01Is Luye Pharma Group Ltd. (HKG:2186) Popular Amongst Institutions?
Jan 06Financial Position Analysis
Short Term Liabilities: 2186's short term assets (CN¥10.7B) exceed its short term liabilities (CN¥8.1B).
Long Term Liabilities: 2186's short term assets (CN¥10.7B) exceed its long term liabilities (CN¥3.8B).
Debt to Equity History and Analysis
Debt Level: 2186's net debt to equity ratio (16.6%) is considered satisfactory.
Reducing Debt: 2186's debt to equity ratio has reduced from 77.4% to 61.7% over the past 5 years.
Debt Coverage: 2186's debt is well covered by operating cash flow (20.8%).
Interest Coverage: 2186's interest payments on its debt are not well covered by EBIT (1.9x coverage).